LMAT R&D to Revenue

Lemaitre Vascular Inc · R&D to Revenue

LMAT logo

LMAT R&D to Revenue

Latest reported6.89%
LMAT Quarterly R&D/Revenue (0.00% → 6.89%)
High-resolution chart · PNG

LMAT r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Lemaitre Vascular Inc R&D to Revenue — Quarterly
Period endingR&D to Revenue
6.8867%
6.1006%
5.4815%
4.8652%
5.5128%
6.8397%
6.4935%
6.6692%
7.6707%
7.6517%
8.9008%
8.9093%
9.0113%
8.2315%
8.678%
8.8706%
7.9462%
7.4113%
8.7512%
7.4229%
6.5208%
7.9258%
7.6409%
5.7612%
8.6073%
9.8%
8.2831%
7.8385%
7.6519%
7.8654%
8.2673%
8.4295%
7.3575%
7.0209%
6.0528%
7.0945%
6.3449%
6.8686%
6.5313%
6.629%
7.2982%
7.1379%
7.6893%
7.4691%
6.6895%
6.0801%
5.7866%
6.3368%
6.2607%
8.022%
7.8254%
8.4967%
7.9493%
8.2759%
10.5466%
9.2415%
7.9033%
8.1491%
8.493%
6.6877%
6.8819%
8.7135%
10.2211%
8.3114%
9.4505%
11.1473%
12.6325%
10.8497%
11.3618%
11.5527%
10.7423%
10.0058%
11.5708%
11.3953%
10.5818%
11.2776%
10.8386%
11.6766%
8.1649%
9.4262%
11.2557%
9.2755%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.